• Trending
  • Latest
    Sign in Sign up
    • Log In
    • Register
    • Home
    • Discover
    • Experts
    • Home
    • Discover
    • Experts
    • Home
    • Discover
    • Experts
    • Mashup Score: 3
      Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours - 7 hour(s) ago

      Nature – A study reporting the results of a clinical trial co-administering the GDF-15-blocking antibody visugromab with the anti-PD-1 antibody nivolumab demonstrates that neutralizing GDF-15 can…

      Source: www.nature.com
      Categories: General Medicine News, General HCPs
      Tweet Tweets with this article
      • Profile photo of medical_xpress
        medical_xpress

        Blocking GDF-15 may enhance the effectiveness of immune checkpoint inhibitors in resistant #SolidTumors, as shown in a clinical trial. This approach could offer new hope for challenging #Cancer cases. @nature https://t.co/xnZg2CUENR https://t.co/kHgcv1m8w7

    Advertisement

    Advertisement

    MashupMD
    © 2024 - Mashup Media LLC
    • Terms of Use
    • Privacy Policy